Neopterin is associated with cardiovascular events and all-cause mortality in renal transplant patients

Inflammatory markers show significant associations with cardiovascular events and all‐cause mortality after kidney transplantation. Neopterin, reflecting interferon‐γ‐release, may better reflect the proinflammatory state of recipients than less specific markers.

[1]  G. Sulo,et al.  Neopterin and kynurenine-tryptophan ratio as predictors of coronary events in older adults, the Hordaland Health Study. , 2013, International journal of cardiology.

[2]  J. Gostner,et al.  Redox regulation of the immune response , 2013, Redox report : communications in free radical research.

[3]  E. Kaminski,et al.  Serum neopterin as an indicator of increased risk of renal allograft rejection. , 2013, Transplant immunology.

[4]  A. Gaipov,et al.  The Relationship between Oxidative Stress, Inflammation, and Atherosclerosis in Renal Transplant and End-Stage Renal Disease Patients , 2012, Renal failure.

[5]  V. Jha,et al.  Association between Serum Neopterin and Inflammatory Activation in Chronic Kidney Disease , 2012, Mediators of inflammation.

[6]  W. März,et al.  Osteoprotegerin as a predictor of renal and cardiovascular outcomes in renal transplant recipients: follow-up data from the ALERT study. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[7]  P. Heeger,et al.  Transplant immunology for non-immunologist. , 2012, The Mount Sinai journal of medicine, New York.

[8]  P. Stenvinkel,et al.  Dialysis in 2011: Can cardiovascular risk in dialysis patients be decreased? , 2012, Nature Reviews Nephrology.

[9]  M. Nafar,et al.  Oxidative stress in kidney transplantation: causes, consequences, and potential treatment. , 2011, Iranian journal of kidney diseases.

[10]  W. März,et al.  Inflammation-associated graft loss in renal transplant recipients. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[11]  A. Jardine,et al.  Prevention of cardiovascular disease in adult recipients of kidney transplants , 2011, The Lancet.

[12]  T. Mueller,et al.  Macrophage activation is associated with poorer long‐term outcomes in renal transplant patients , 2011, Clinical transplantation.

[13]  M. Chiariello,et al.  Neopterin: from forgotten biomarker to leading actor in cardiovascular pathophysiology. , 2011, Current vascular pharmacology.

[14]  D. Fuchs,et al.  Inflammation, adiponectin, obesity and cardiovascular risk. , 2010, Current medicinal chemistry.

[15]  N. Punjabi,et al.  Serum levels of the immune activation marker neopterin change with age and gender and are modified by race, BMI, and percentage of body fat. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[16]  J. Kaski,et al.  Neopterin levels and left ventricular dysfunction in patients with chronic stable angina pectoris. , 2009, Atherosclerosis.

[17]  D. Fuchs,et al.  The role of neopterin in atherogenesis and cardiovascular risk assessment. , 2009, Current medicinal chemistry.

[18]  K. Midthjell,et al.  Neopterin predicts the risk for fatal ischemic heart disease in type 2 diabetes mellitus: long-term follow-up of the HUNT 1 study. , 2009, Atherosclerosis.

[19]  W. März,et al.  Inflammation in renal transplantation. , 2009, Clinical journal of the American Society of Nephrology : CJASN.

[20]  D. Fuchs,et al.  Neopterin as a predictor of total and cardiovascular mortality in individuals undergoing angiography in the Ludwigshafen Risk and Cardiovascular Health study. , 2009, Clinical chemistry.

[21]  M. Erdogan,et al.  Alterations in l-arginine and inflammatory markers in type 2 diabetic patients with and without microalbuminuria , 2009, Acta Diabetologica.

[22]  E. Kaminski,et al.  The value of serum neopterin, interferon‐gamma levels and interleukin‐12B polymorphisms in predicting acute renal allograft rejection , 2008, Clinical and experimental immunology.

[23]  E. Çakır,et al.  Relations between Concentrations of Asymmetric Dimethylarginine and Neopterin as Potential Risk Factors for Cardiovascular Diseases in Haemodialysis-Treated Patients , 2008, Renal failure.

[24]  M. Sabatine,et al.  Long-Term Prognostic Value of Neopterin: A Novel Marker of Monocyte Activation in Patients With Acute Coronary Syndrome , 2007, Circulation.

[25]  S. Takahara,et al.  Serum and urinary neopterin as markers in renal transplant patients , 2007, International Urology and Nephrology.

[26]  W. Padberg,et al.  Post‐Transplant sCD30 and Neopterin as Predictors of Chronic Allograft Nephropathy: Impact of Different Immunosuppressive Regimens , 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[27]  A. Bakr,et al.  Serum neopterin levels in children with primary nephrotic syndrome , 2003, Acta paediatrica.

[28]  A. Hartmann,et al.  Long‐term Cardiac Outcomes in Renal Transplant Recipients Receiving Fluvastatin: The ALERT Extension Study , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[29]  W. Padberg,et al.  sCD30 and neopterin as risk factors of chronic renal transplant rejection: impact of cyclosporine A, tacrolimus, and mycophenolate mofetil. , 2005, Transplantation proceedings.

[30]  J. Wolf,et al.  Neopterin im Serum und Urin zur Differentialdiagnose von Nierenfunktionsstörungen nach Nierentransplantation , 1987, Klinische Wochenschrift.

[31]  D. Fuchs,et al.  Increasing production of homocysteine and neopterin and degradation of tryptophan with older age. , 2004, Clinical biochemistry.

[32]  M. Arias,et al.  Proteinuria: a new marker of long-term graft and patient survival in kidney transplantation. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[33]  D. Fuchs,et al.  Potential role of immune system activation-associated production of neopterin derivatives in humans , 2003, Inflammation Research.

[34]  I. Holme,et al.  Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial , 2003, The Lancet.

[35]  D. Fuchs,et al.  Factors influencing serum neopterin concentrations in a population of blood donors. , 2002, Clinical chemistry.

[36]  Grebe So,et al.  Immune monitoring in organ transplantation using neopterin. , 2002 .

[37]  T. Mueller,et al.  Immune monitoring in organ transplantation using neopterin. , 2002, Current drug metabolism.

[38]  R. Zietse,et al.  PROTEINURIA AFTER RENAL TRANSPLANTATION AFFECTS NOT ONLY GRAFT SURVIVAL BUT ALSO PATIENT SURVIVAL , 2001, Transplantation.

[39]  I. Holme,et al.  Effects of Fluvastatin on Cardiac Events in Renal Transplant Patients: ALERT (Assessment of Lescol® in Renal Transplantation) Study Design and Baseline Data , 2001, Journal of cardiovascular risk.

[40]  R. Rodby,et al.  Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy , 1998 .

[41]  R. Rodby,et al.  Free pentosidine and neopterin as markers of progression rate in diabetic nephropathy. Collaborative Study Group. , 1998, Kidney international.

[42]  P. Lee,et al.  Monitoring of serum neopterin in renal transplant recipients. , 1992, Journal of the Formosan Medical Association = Taiwan yi zhi.

[43]  E. Werner,et al.  POSTTRANSPLANT NEOPTERIN EXCRETION IN RENAL ALLOGRAFT RECIPIENTS—A RELIABLE DIAGNOSTIC AID FOR ACUTE REJECTION AND A PREDICTIVE MARKER OF LONG‐TERM GRAFT SURVIVAL , 1991, Transplantation.

[44]  H. Tilg,et al.  In-vitro and in-vivo studies on the induction of neopterin biosynthesis by cytokines, alloantigens and lipopolysaccharide (LPS). , 1988, Clinical and experimental immunology.

[45]  H. Tilg,et al.  Comparison of serum neopterin levels and urinary neopterin excretion in renal allograft recipients. , 1988, Clinical nephrology.

[46]  E. Musch,et al.  [Neopterin in the serum and urine in the differential diagnosis of disorders of kidney function following kidney transplantation]. , 1987, Klinische Wochenschrift.

[47]  G. Opelz,et al.  ASSESSMENT OF PLASMA NEOPTERIN IN CLINICAL KIDNEY TRANSPLANTATION , 1986, Transplantation.

[48]  D. Fuchs,et al.  Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma , 1984, The Journal of experimental medicine.

[49]  D. Fuchs,et al.  Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. , 1983, Transplantation.

[50]  G. Brown,et al.  THE BIOSYNTHESIS OF FOLIC ACID. IV. ENZYMATIC SYNTHESIS OF DIHYDROFOLIC ACID FROM GUANINE AND RIBOSE COMPOUNDS. , 1964, The Journal of biological chemistry.